Arecor Therapeutics Investor Relations Material

Arecor Therapeutics PLC is a biopharmaceutical company specializing in the development of enhanced pharmaceutical formulations. The company applies its proprietary technology to improve the stability, efficacy, and delivery of existing biologics, peptides, and therapeutic proteins. Its pipeline includes proprietary and partnered programs focused on diabetes, critical care, and other therapeutic areas. The company is headquartered in Cambridge, United Kingdom, and its shares are listed on the London Stock Exchange (LSE).